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To the Editor:
Electronic cigarettes (e-cigarettes) have been used in many countries for >10 years and in this time, there
has been a division of opinions amongst both the general public and health professionals regarding the
benefit or harms of e-cigarettes. Prior to the reporting of a new phenomenon known as vaping-associated
pulmonary injury (VAPI), public opinion about the relative harm of e-cigarettes were increasing but they
were perceived as less harmful than cigarettes by one third of people [1]. The recent cases of severe illness
and death attributable to VAPI were first described in September 2019 [2]. VAPI appears to be related to
either the addition of cannabis/cannabis derivates or vitamin E acetate [3], and as such has not caused
radical swing away from the use of e-cigarettes without cannabis or cannabis derivates.
Thirdhand cigarette exposure occurs when the toxicants found in cigarette smoke are absorbed by the
environment (clothing, surfaces, dust, etc.). These then become a new environmental source of cigarette
smoke toxicants, and are of particular concern to nonsmokers such as babies crawling on surfaces or
exposed to the clothing of smokers. E-cigarettes have been shown to be a potential source of thirdhand
exposure to nicotine [4], and therefore need to be evaluated in the same context as thirdhand cigarette
smoking.
We have a long-standing interest in the potential health effects of e-cigarettes in children, and for example,
we were the first group to show that e-cigarette use in pregnancy is likely to have detrimental effects upon
the respiratory, renal and neurological health of the offspring [5–9]. One area of e-cigarette research where
experimental data are lacking is thirdhand exposure. A search of PubMed (18 December 2019) found only
13 papers using the search term “e-cigarettes” and “thirdhand exposure”, and of the 13, four were studies
measuring nicotine in thirdhand environmental e-cigarette samples and the rest were reviews on the topic.
In the current study, we have chosen to explore the potential harms of thirdhand e-cigarette exposure
during early-life development. For obvious ethical reasons, we have explored this in a novel mouse model
of exposure. We hypothesised that like thirdhand exposure to cigarettes, thirdhand exposure to e-cigarettes
would have detrimental effects on childhood health.
To mimic the potential exposure that a human infant would have if they crawled on contaminated carpets
or came into contact with the clothing of a vaper, we exposed a new towel (15×10 cm, 100% cotton) to the
e-vapour generated by 20×5-s bursts of nicotine-free or nicotine-containing (18 mg·mL−1) e-liquid
(tobacco flavour; Vaper Empire, Sydney, Asutralia) by a human e-cigarette machine (30 W, 0.5 Ω, 20
puffs) (NEBOX; KangerTech, Shenzhen, China) in a sealed 9-L container for 2 h. Each day, a freshly
exposed towel was placed in the mouse cage (male, Balb/C, 4 weeks old). At the end of the 8 days of
exposure, mice were sacrificed, and body and organ weights were assessed. Ethical approval was given by
the Animal Care and Ethics Committee at the University of Technology Sydney (ETH18-2890), following
the guidelines of the National Health and Medical Research Council, Australia. Serum cytokines and
chemokines were assessed by a MAGPIX (Luminex, Austin, TX, USA) multiplexing system, and lung
@ERSpublications
Thirdhand exposure to e-cigarette residue is likely to have harmful effects in children http://bit.
ly/38a2umw
Cite this article as: Chen H, Li G, Allam VSRR, et al. Evidence from a mouse model on the
dangers of thirdhand electronic cigarette exposure during early life. ERJ Open Res 2020; 6: 00022-
2020 [https://doi.org/10.1183/23120541.00022-2020].
Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution Non-
Commercial Licence 4.0.
https://doi.org/10.1183/23120541.00022-2020 ERJ Open Res 2020; 6: 00022-2020
ORIGINAL RESEARCH LETTER
inflammatory cell counts were assessed in bronchoalveolar lavage fluid (BALF). Chemicals in the towel
were extracted using methanol and analysed using gas chromatography–mass spectrometry (GC-MS).
As shown in figure 1, nicotine was transferred from the towel to the mouse, leading to the hypothesis that
other toxic components of the e-cigarette vapour would also be transferred to the animal. To assess the
general development of the animal, both body weight and the weights of the spleen, liver, kidneys and
brain were measured at the end of the exposure period. Body weight was not affected by thirdhand
exposure to e-cigarettes and neither was the weight of the liver or kidneys (not shown). However, both the
spleen and the brains were smaller in the groups exposed to thirdhand e-vapour with or without nicotine
(figure 1). This suggests that the development of these organs is impaired by thirdhand exposure to
e-vapour. 33 different cytokines and chemokines were assessed in the serum of sham and thirdhand
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FIGURE 1 a) Serum cotinine (n=3), b) CCL1, c) CCL2, d) CCL4, e) CCL7, f ) tumour necrosis factor (TNF) (n=8–10) and f) eotaxin (n=3–4)) from mice
with thirdhand exposure to tobacco flavoured e-vapour without (0 mg) or with (18 mg) nicotine, or sham exposed for 8 days. Bronchoalveolar h)
total cell and i) macrophage counts (n=7–9), j) spleen and k) brain weights (n=8–12), and l) airway reactivity (Rrsmax) (n=8–9) to inhaled
methacholine from the same groups. Data were analysed by one- or two-way ANOVA with an appropriate post hoc test (Fisher’s least significant
difference, Welch’s correction or Tukey as appropriate). *: p<0.05 versus sham; **: p<0.01 versus sham; ***: p<0.001 versus sham; #: p<0.05 for
18 mg versus sham.
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CCL1, CCL2, CCL4, CCL7 and tumour necrosis factor in the serum, and surprisingly, thirdhand e-vapour
with nicotine had no effect on these cytokines. The only mediator that was found to be elevated in serum
was CCL11 (eotaxin), which was significantly induced by nicotine-containing thirdhand e-vapour.
In this study, we were principally interested in the effects of thirdhand e-vapour exposure on the lungs. To
assess inflammation, inflammatory cell counts in the BALF were carried out, and total cell numbers were
markedly decreased in the thirdhand e-vapour without nicotine group, which was caused by a reduction in
macrophage numbers in the BALF. Similar to what was observed in serum, thirdhand e-vapour with
nicotine did not affect macrophage numbers. Lung function was also assessed, and it was found that upon
thirdhand exposure to e-cigarettes with nicotine, the lungs were hyporesponsive to methacholine (figure 1).
Our data demonstrate, for the first time, that toxicants found in thirdhand e-cigarette vapour are
biologically relevant. Our model is relatively acute, in that exposure only occurred for 8 days. Even with
this short-term exposure, cotinine levels in the serum are equivalent to what might be found in a light
cigarette smoker. One of the most startling findings of our study was that thirdhand e-cigarettes without
nicotine suppressed the immune system by inhibiting several chemokines. CCL1, CCL2, CCL4 and CCL7
are chemokines that attract macrophages, and therefore the reduction in macrophage numbers in BALF is
in accordance with these changes. Thirdhand exposure to e-vapour with nicotine reversed the suppression
of the immune system, consistent with the anti-inflammatory effect of nicotine [10]. Airway
hyporesponsiveness in animals exposed to e-vapour with nicotine might be caused by downregulation or
occupancy of the nicotinic acetylcholine receptors, and interestingly, has occurred in animal models of
cigarette smoking [11]. The suppression of the development of the brain following thirdhand exposure of
e-cigarettes, especially in the group without nicotine, suggests a paradigm shift in the proposed roles of
nicotine as a suppressor of brain development in smoker’s offspring [12]. This suggests that other
chemical(s) may play a critical role. To identify the chemicals in the towel, chemicals were extracted using
methanol and analysed using GC-MS. Although formaldehyde, acetaldehyde, benzene, phenol and
benzaldehyde were detected in the e-vapour, only nicotine and propylene glycol were detected in the
towel. Interestingly, propylene glycol has been shown to be detrimental to the developing brain [13].
However, another method is still needed in future studies to identify other toxic chemical(s) responsible
for the suppression of organ development.
In conclusion, thirdhand exposure of e-cigarettes is highly likely to have detrimental effects on children,
and in other high-risk groups such as pregnant women. We believe our data demonstrate that thirdhand
exposure of e-cigarettes should be considered to be as dangerous as thirdhand cigarette exposure.
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